Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPRC-AB01 in post-surgical chronic sinusitis
NCT00447837Phase 2Completed
- Sponsor
- Naryx Pharmaceuticals
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tobramycin in sinusitis (3 arms), sponsored by Naryx Pharmaceuticals. Primary endpoint: Total Symptom Severity Score at 86 days. Started Oct 2006; status: completed.
02
Drugs
tobramycin
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT00447837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447837.